Molecular weight determination of intact recombinant therapeutic proteins is a challenging analytical tool which furnishes valuable information not only for protein structure characterization but also to assess purity and heterogeneity. Up to now several mass spectrometric (MS) approaches have been reported for the measurement of monoisotopic or average masses of intact recombinant therapeutic protein. The choice of a suitable approach depends on several factors, among which are the sample complexity and homogeneity and the size of the target protein. MALDI-TOF, since it is rapid, simple and adaptable for automation has been found suitable for in-process monitoring quality of low/middle protein. High resolution MS such as Q-TOF, orbitrap and FT-ICR are excellent analytical tools for assessing protein heterogeneity and for structural characterization, in some cases without the need for proteolytic digestion and analysis of resulting products. High resolution techniques such as capillary electrophoresis (CE) and UPLC have been successfully coupled to high resolution MS analyzers in cases where the sample is complex and highly heterogeneous. The paper is a review of the most used and advanced MS strategies so far reported as well as of their applications in the biopharmaceutical field.

Mass Spectrometric Strategies and their Applications for Molecular Mass Determination of Recombinant Therapeutic Proteins / M. Carini, L.G. Regazzoni, G. Aldini. - In: CURRENT PHARMACEUTICAL BIOTECHNOLOGY. - ISSN 1389-2010. - 12:10(2011), pp. 1548-1557.

Mass Spectrometric Strategies and their Applications for Molecular Mass Determination of Recombinant Therapeutic Proteins

M. Carini
Primo
;
L.G. Regazzoni
Secondo
;
G. Aldini
Ultimo
2011

Abstract

Molecular weight determination of intact recombinant therapeutic proteins is a challenging analytical tool which furnishes valuable information not only for protein structure characterization but also to assess purity and heterogeneity. Up to now several mass spectrometric (MS) approaches have been reported for the measurement of monoisotopic or average masses of intact recombinant therapeutic protein. The choice of a suitable approach depends on several factors, among which are the sample complexity and homogeneity and the size of the target protein. MALDI-TOF, since it is rapid, simple and adaptable for automation has been found suitable for in-process monitoring quality of low/middle protein. High resolution MS such as Q-TOF, orbitrap and FT-ICR are excellent analytical tools for assessing protein heterogeneity and for structural characterization, in some cases without the need for proteolytic digestion and analysis of resulting products. High resolution techniques such as capillary electrophoresis (CE) and UPLC have been successfully coupled to high resolution MS analyzers in cases where the sample is complex and highly heterogeneous. The paper is a review of the most used and advanced MS strategies so far reported as well as of their applications in the biopharmaceutical field.
Mass spectrometry - Recombinant pharmaceutical proteins - Biopharmaceuticals
Settore CHIM/08 - Chimica Farmaceutica
2011
Article (author)
File in questo prodotto:
File Dimensione Formato  
CURR PHARM BIOTECH_2011.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 132.46 kB
Formato Adobe PDF
132.46 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/166162
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 15
social impact